Cite
Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer.
MLA
Yang, Fan‐Wei, et al. “Multipathway Regulation Induced by 4‐(Phenylsulfonyl)Morpholine Derivatives against Triple‐negative Breast Cancer.” Archiv Der Pharmazie, vol. 357, no. 5, May 2024, pp. 1–20. EBSCOhost, https://doi.org/10.1002/ardp.202300435.
APA
Yang, F., Mai, T., Lin, Y. J., Chen, Y., Kuo, S., Lin, C., Lee, M., & Su, J. (2024). Multipathway regulation induced by 4‐(phenylsulfonyl)morpholine derivatives against triple‐negative breast cancer. Archiv Der Pharmazie, 357(5), 1–20. https://doi.org/10.1002/ardp.202300435
Chicago
Yang, Fan‐Wei, Te‐Lun Mai, Ying‐Chung Jimmy Lin, Yu‐Chen Chen, Shang‐Che Kuo, Chia‐Ming Lin, Meng‐Hsuan Lee, and Jung‐Chen Su. 2024. “Multipathway Regulation Induced by 4‐(Phenylsulfonyl)Morpholine Derivatives against Triple‐negative Breast Cancer.” Archiv Der Pharmazie 357 (5): 1–20. doi:10.1002/ardp.202300435.